Insights: Our new content offering a deeper look at the pharmaceutical industry

The pharmaceutical sector is complex, with multiple challenges and stakes. Because it is essential to us to help our readers understand it better, we have added a new section. Called Insights, this content is dedicated to key subjects affecting the pharmaceutical industry. With topics such as the urgency of innovating for patients, the necessity for significant R&D investment, and the societal and environmental challenges involved in what we do, our goal is to shed light for our readers on these everyday issues that face our industry.

Joined by experts in their respective fields, we will give you an opportunity to discover the key scientific topics of current relevance to our sector. On the agenda are deep dives into sector-specific issues, meetings with leaders and stakeholders from the health world, and hearing what the patients themselves have to say.

Presented from different angles, our new section will give you in-depth insights into the pharmaceutical industry:

• Crystal clear: a deep dive into a scientific subject
• Science calling: a focus on a scientific innovation subject
• Tell me a story: from the viewpoints of partners, academics, peers, and patient organizations
• Futures forum: forward-looking content on the challenges encountered by the pharmaceutical industry
• Sounding out patients: when patients take the floor

In our first article to be published in the coming days, we will take you to delve into the world of a biotech startup, SparingVision. This startup is specialized in developing therapeutic solutions for patients with retinal diseases. Insights followed several teams — from R&D, quality, and support functions — to understand the key moments that shape their lives and the challenges they have to face.

00:00 / 00:00